Christopher deFilippi Selected Research

Christopher deFilippi Research Topics

Disease

17	Heart Failure 05/2022 - 01/2013
10	Myocardial Infarction 05/2022 - 07/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 01/2013
6	Chronic Renal Insufficiency 11/2019 - 05/2009
5	Inflammation (Inflammations) 05/2022 - 09/2014
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 05/2009
3	Fibrosis (Cirrhosis) 05/2022 - 01/2018
3	Chest Pain (Chest Pains) 01/2020 - 05/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2015 - 07/2003
2	Unstable Angina 10/2020 - 05/2015
2	Dyspnea (Shortness of Breath) 01/2020 - 04/2015
2	Atherosclerosis 12/2019 - 10/2017
2	Hypertension (High Blood Pressure) 12/2019 - 05/2015
2	Left Ventricular Dysfunction 02/2013 - 01/2013
2	Acute Coronary Syndrome 09/2012 - 07/2003
1	Arteritis 11/2022
1	ST Elevation Myocardial Infarction 05/2022
1	Shock 05/2022
1	Thrombosis (Thrombus) 05/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Anemia 11/2021
1	COVID-19 01/2021
1	Ventricular Tachycardia 12/2020
1	Stroke (Strokes) 10/2020
1	Proteinuria 11/2019
1	Venous Thromboembolism 10/2017
1	Atrial Fibrillation 05/2015
1	Ventricular Remodeling 04/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2013
1	Hypertrophy 02/2013
1	Coronary Disease (Coronary Heart Disease) 09/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2003
1	Cardiomyopathies (Cardiomyopathy) 07/2003

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2013
9	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2013
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 02/2013
8	TroponinIBA 01/2020 - 09/2012
7	Troponin T (Troponin T1)IBA 12/2020 - 07/2003
5	Troponin IIBA 01/2021 - 09/2012
3	Growth Differentiation Factor 15IBA 05/2022 - 01/2018
3	Galectin 3 (LGALS3)IBA 12/2020 - 06/2014
2	CholesterolIBA 05/2022 - 11/2019
2	MineralsIBA 05/2022 - 11/2019
2	trans-crotonin (CTN)IBA 10/2020 - 01/2020
2	C-Reactive ProteinIBA 09/2014 - 07/2003
2	Fibroblast Growth Factor-23IBA 01/2013 - 05/2009
1	Biological ProductsIBA 11/2022
1	AldosteroneIBA 11/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2022
1	Trefoil Factor-3IBA 05/2022
1	Tartrate-Resistant Acid PhosphataseIBA 05/2022
1	CollagenIBA 05/2022
1	Interleukin-1 (Interleukin 1)IBA 05/2022
1	LDL Receptors (LDL Receptor)IBA 05/2022
1	Protein Tyrosine PhosphatasesIBA 05/2022
1	Galectin 4 (LGALS4)IBA 05/2022
1	Metalloproteases (Metalloproteinases)IBA 05/2022
1	OsteoprotegerinIBA 05/2022
1	Cathepsin ZIBA 05/2022
1	Torsemide (Demadex)FDA LinkGeneric 03/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	Furosemide (Lasix)FDA LinkGeneric 03/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	vericiguatIBA 11/2021
1	Flecainide (Tambocor)FDA LinkGeneric 12/2020
1	sacubitrilIBA 01/2020
1	Neprilysin (Neutral Endopeptidase)IBA 01/2020
1	CalciumIBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Valsartan (Vals)FDA Link 01/2020
1	Natriuretic PeptidesIBA 01/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 12/2019
1	Trinitrotoluene (TNT)IBA 08/2019
1	Lipopolysaccharide ReceptorsIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	vinyltriethoxysilane (VTES)IBA 10/2017
1	omega-Chloroacetophenone (Mace)IBA 05/2015
1	proadrenomedullinIBA 05/2015
1	Eplerenone (Inspra)FDA LinkGeneric 04/2015

Therapy/Procedure

3	Therapeutics 05/2022 - 01/2018
1	Percutaneous Coronary Intervention 05/2022
1	Patient Readmission 06/2014
1	Renal Dialysis (Hemodialysis) 07/2003